Home Tags Generic Drugs
Tag: Generic Drugs
250 more hospitals just joined in on a plan to make their own drugs and the effort could upend the generic pharma business
Another 12 health systems joined an organization aiming to lower the price of prescription drugs. The hope is to make generic drugs that are in shortage or have high prices.
Dispensed: A lawsuit accuses 20 drug companies of cozying up to raise drug prices, dispatches from Seattle, and 2019 predictions
Welcome to Dispensed: A weekly dose of pharma, biotech, and healthcare news.
A smiley-face text message about hiking the price of an old drug is at the center of a massive lawsuit being brought against nearly 20 big drug compan...
The allegation is part of a larger civil antitrust complaint being brought by most US states regarding price hikes on a number of generic drugs.
A huge lawsuit accuses nearly 20 big drug companies, a billionaire, and 2 brothers-in-law of cozying up to hike drug prices. Here’s the inside s...
Business Insider is the first to report on the unredacted suit, which alleges frequent, close communications among employees of rival companies about how to increase prices.
A group of hospitals just picked a CEO to run their nonprofit generic drug company — and he’s not getting paid to do it
A group of hospitals have built a nonprofit generic drugmaker called Civica Rx. The company will be led by pharma veteran Martin VanTrieste who won't be compensated for his work. The hope is to make generic drugs that are in shortage or have artificially high prices based on what hospitals need.
The Food and Drug Administration, oversees among other things drug approvals. On Thursday, the agency published a list of 52 drugs it deemed are facing delays to getting generic versions because of "gaming" happening on the part of brand drugmakers.
Amazon could be getting into healthcare, and the company's reportedly had conversations with generic drugmakers about it, CNBC reports.
A lawsuit over price fixing by drugmakers is being massively expanded and shares of Mylan are plunging
The states are zeroing in on a man named Rajiv Malik, Mylan's president and executive director, along with Satish Mehta, CEO at Emcure Pharmaceuticals.
Allergan, the drugmaker behind Botox, just got the patents on one of its blockbuster eye drug invalidated.
New York's attorney general — along with the AGs of 19 other states — has filed a lawsuit against generic drugmakers for fixing prices and colluding.